09.03.24 -- The Influence Of Flows In cGMP Architectural Design

The revised Annex 1 focuses on harmonizing regulations across the pharmaceutical manufacturing industry, prompting the industry to strategize to achieve the best compliance method.

Dig deep into some of the compelling reasons to move from on-premise to a cloud-based laboratory data management system.

Explore a framework demonstrating the value of adopting a digital, data-centric approach to validation management to executives and stakeholders.

A phase-appropriate quality approach ensures quality activities align with the unique risks and challenges of each development phase. Watch to learn how to apply such an approach to CMC planning.

Learn about FDA regulation 21 CFR Part 11 and the critical role it plays in ensuring pharmaceutical and medical product manufacturers properly manage and track their data.

Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

Establishing a chemistry, manufacturing, and controls strategy that proves a clinical program is tightly controlled and can address risk is critical to avoiding the pitfalls that stall many promising therapeutics.

Explore a detailed process for validating ligand-binding assays, particularly for Fcγ receptor binding analytes or other structural isoforms.

Watch to gain a comprehensive understanding of water activity testing as well as how to effectively use non-destructive headspace analysis to generate dependable water activity data.

Federal Equipment's Matt Hicks was interviewed by Don Davison on the Life Science Success podcast. Hear them discuss Matt’s career and how Federal Equipment buys and sells pharmaceutical equipment.

The heterogeneity of a biologic product has implications for the final therapy's safety and efficacy. Explore challenges associated with charged variants, including mAbs and fusion proteins.